Plus: The State of Psychedelics and The Latest in Oregon
11
1
Brown on the history and future of ibogaine research in the U.S.
22
3
Plus: The State of Psychedelics and the Latest in Oregon
10
Plus: The Latest in Oregon and The State of Psychedelics
16
6
Rais on how psychedelic insurance coverage works and the company’s plan for growth.
23
2
Plus: The Latest in Oregon, and could hype hurt clinical trials?
19
1
Plus: The Latest in Oregon, and the State of Psychedelics
15
1
Sam Chapman is a sort of front man for drug policy reform in Oregon. Recently, he’s been spending a lot of hours in Zoom meetings talking with local…
22
Zorn on the role of litigation in the so-called psychedelic renaissance.
32
5
Devenot discusses their research and the upcoming meeting of Psychedemia, a conference they founded a decade ago.
35
5
Plus: SB 519 back in play, and still more Oregon counties look to opt-out of psilocybin services
13
4
Senator Wiener on SB 519 and the concerns around the language used in the bill.
35
2